# Bank of America

Type: Company (BAC)

Source: Healthcare Intelligence Brief — https://gethealthbrief.com/entity/bank-of-america-company
Canonical HTML page: https://gethealthbrief.com/entity/bank-of-america-company

## Recent coverage (3 stories)

### Novavax Cut to Sell by Wall Street Zen as Stock Trades at $7.41
2026-08-04 12:11:39 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Wall Street Zen downgraded vaccine maker Novavax to sell, raising alarms in the healthcare sector. The stock traded at $7.41, far below its $13 consensus target, with a negative P/E of -12.78.
Full story: https://gethealthbrief.com/story/novavax-sell-downgrade-wall-street-zen-health

### Intuitive Surgical’s 28% Stock Drop: Goldman Says New Instrument Lifespans Boost Hospital Adoption
2026-07-04 10:21:14 · Sentiment: Bullish · Impact: 6/10 · Sources: 2

Intuitive Surgical's decision to extend force-feedback tool usage from 6 to 15 uses could accelerate robotic surgery adoption in hospitals, easing supply chain woes and lowering per-procedure costs without sacrificing revenue.
Full story: https://gethealthbrief.com/story/intuitive-surgical-instrument-lifespan-adoption-hospitals

### BofA Lifts Johnson & Johnson Price Target on Robust Pipeline Momentum
2026-03-12 08:11:39 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Bank of America has raised its price target for Johnson & Johnson (JNJ), citing a strengthened outlook for the company's pharmaceutical and MedTech pipelines. The upgrade reflects growing investor confidence in JNJ's post-Kenvue strategy, which prioritizes high-margin innovation in oncology, immunology, and surgical robotics.
Full story: https://gethealthbrief.com/story/bofa-raises-jnj-price-target-pipeline-growth

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://gethealthbrief.com/guides/methodology for the full editorial methodology.